Piershale Financial Group, Inc. Brainstorm Cell Therapeutics Inc. Put Options Transaction History
Piershale Financial Group, Inc.
- $157 Million
- Q2 2023
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BCLI
# of Institutions
5Shares Held
500KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY386KShares$510,0660.0% of portfolio
-
Raymond James & Associates St Petersburg, FL95.2KShares$125,6010.0% of portfolio
-
S.C. Financial Services, Inc.12.7KShares$16,7450.03% of portfolio
-
Institutional & Family Asset Management, LLC6KShares$7,9200.0% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $48.2M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...